Home » GPC Feeling the Pressure
GPC Feeling the Pressure
Just weeks after disappointing news regarding its potential billion-dollar drug satraplatin was swiftly followed by a class action lawsuit against the company, GPC Biotech has announced plans to cut 15 percent of its workforce.
US-PharmaTechnologist.com
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May